Your medical intake form, provider consultations, prescribed medication and syringes, and overnight shipping are all included in the monthly price
April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)
But that has not been established in humans, and there are very limited ongoing clinical trials to illuminate the real efficacy and safety of these peptides
BPC-157 is most commonly administered through subcutaneous injection, although oral capsules/tinctures, nasal sprays, and topical forms are also discussed
This prescription medication offers significant benefits for patients who have struggled with blood sugar control and weight management, providing a dual approach to improving overall health